Mahonia aquifolium extract

Drug Profile

Mahonia aquifolium extract

Alternative Names: Oregon grape extract; Primaderm

Latest Information Update: 19 Jul 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Prime Pharmaceutical Corporation
  • Class Antipsoriatics; Isoquinolines
  • Mechanism of Action 5-lipoxygenase inhibitors; Antioxidants; Free radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Psoriasis

Most Recent Events

  • 19 Jul 1999 A study in patients with psoriasis has been added to the adverse events and therapeutic trials sections
  • 30 Jun 1999 Launched for Psoriasis in Canada (Topical)
  • 30 Jun 1999 Launched for Psoriasis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top